Mr. Alan Simpson reports

PHARMACORP ANNOUNCES DEFINITIVE AGREEMENT TO ACQUIRE WESTERN CANADA PHARMACHOICE BANNERED PHARMACY

Pharmacorp Rx Inc. has entered into a definitive share purchase agreement dated June 26, 2026, to acquire 100 per cent of the issued and outstanding shares of a Pharmachoice bannered pharmacy located in Western Canada.

"This transaction reflects the continued execution of our acquisition strategy and demonstrates our ability to convert previously announced LOIs into definitive agreements," said Alan Simpson, executive chair of Pharmacorp. "The pharmacy we are acquiring has a strong operating foundation, an established patient base and a transition plan that aligns well with our pharmacist-led operating model."

Further to Pharmacorp's acquisition pipeline update announced on April 30, 2026, in which the corporation disclosed four non-binding letters of intent in additional pharmacy acquisitions, this acquisition represents the second of those four previously announced LOIs to be converted into a definitive share purchase agreement.

Upon completion of the acquisition and assuming completion of the previously announced eight-store acquisition in Eastern Canada and the previously announced Ontario acquisition, Pharmacorp is expected to operate 16 community pharmacies in Canada.

The eight-store acquisition in Eastern Canada remains on track to close in early July, 2026, and the Ontario acquisition remains on track to close in late July, 2026.

Further details of the acquisition

The aggregate purchase price for the acquisition announced today is approximately $2.47-million subject to customary adjustments, and is expected to be financed using the corporation's existing cash resources.

The acquisition is expected to close in late July, subject to customary closing conditions, including receipt of all required regulatory approvals. No finders' fees are payable in connection with the acquisition.

The acquisition is consistent with Pharmacorp's acquisition framework and broader capital allocation strategy, including its disciplined approach to valuation, integration and long-term growth.

The pharmacy's current owner is expected to assist with transition planning following closing. Pharmacorp also anticipates that an existing staff pharmacist will assume the role of managing pharmacist, supporting continuity of patient care, preservation of local relationships and integration into the Pharmacorp platform.

Two remaining previously announced LOIs continue to progress through due diligence and definitive documentation. Pharmacorp continues to evaluate additional acquisition opportunities across Canada in accordance with its disciplined acquisition framework.

About Pharmacorp Rx Inc.

Pharmacorp is a Canadian pharmacy acquisition and ownership platform focused on empowering pharmacists as equity partners and supporting succession for retiring pharmacy owners. Through a combination of capital, strategic support and operational expertise, Pharmacorp is building a national network of community pharmacies under the Pharmachoice Canada banners. Pharmacorp currently operates six Pharmachoice Canada bannered pharmacies, and will continue to acquire both Pharmachoice Canada bannered and independent pharmacies across Canada, rebranding non-bannered locations under the Pharmachoice Canada platform in accordance with its strategic alliance with Pharmachoice Canada. Pharmacorp shares trade on the TSX Venture Exchange under the symbol PCRX.

Pharmacorp welcomes discussions with pharmacy owners considering succession or sale. Pharmacorp is committed to seamless transitions that protect pharmacy owners' legacies and continue serving communities.

We seek Safe Harbor.